Loading organizations...
§ Venture Capital · Chaoyang, Liaoning, China
Venture capital investor that provides funding to support the development and expansion of startups and growth-stage companies.
CTS Capital Solutions provides technology solutions and software development services to the financial industry. The company modernizes intricate data analytics systems, assessing, documenting, and streamlining infrastructure. This reduces maintenance, minimizes downtime, and resolves software bugs, ensuring robust, efficient operational environments.
The firm was founded by Craig Schroeder, leveraging two decades leading large-scale software projects. Schroeder’s profound understanding of development complexities within critical data environments drives focus on enhancing system reliability and developer efficiency.
CTS Capital Solutions serves financial sector firms managing advanced data analytics. Offerings facilitate faster developer onboarding and cultivate resilient, adaptable systems. Envisions empowering institutions with high-performing, maintainable data ecosystems, fostering strategic decision-making and operational agility.
CTS Capital has 3 tracked investments across 3 companies. The latest tracked deal is $20.0M Series A in Tavotek Biotherapeutics in March 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 22, 2021 | Tavotek Biotherapeutics | $20.0M Series A | — | Lanhu Capital, NEW Alliance Capital, Oriza Holdings |
| Aug 1, 2018 | CureGenetics | $17.0M Series A | Qiming Venture Partners | Formic Ventures, Bill Gates, Scott Becker, Ascendin Investment |
| Jul 18, 2018 | Ascentage Pharma | $150.0M Series C | Teng YUE Partners, Lawrence Tian | ArrowMark Partners, CCB International, HDY International Investment |